Article Versions Notes

Noro D, Yoneyama T, Hatakeyama S, Tobisawa Y, Mori K, Hashimoto Y, Koie T, Tanaka M, Nishimura S-I, Sasaki H, et al. Serum Aberrant N-Glycan Profile as a Marker Associated with Early Antibody-Mediated Rejection in Patients Receiving a Living Donor Kidney Transplant. International Journal of Molecular Sciences. 2017; 18(8):1731. https://doi.org/10.3390/ijms18081731

Noro, Daisuke, Tohru Yoneyama, Shingo Hatakeyama, Yuki Tobisawa, Kazuyuki Mori, Yasuhiro Hashimoto, Takuya Koie, Masakazu Tanaka, Shin-Ichiro Nishimura, Hideo Sasaki, and et al. 2017. "Serum Aberrant N-Glycan Profile as a Marker Associated with Early Antibody-Mediated Rejection in Patients Receiving a Living Donor Kidney Transplant" International Journal of Molecular Sciences 18, no. 8: 1731. https://doi.org/10.3390/ijms18081731

Noro, D., Yoneyama, T., Hatakeyama, S., Tobisawa, Y., Mori, K., Hashimoto, Y., Koie, T., Tanaka, M., Nishimura, S. -I., Sasaki, H., Saito, M., Harada, H., Chikaraishi, T., Ishida, H., Tanabe, K., Satoh, S., & Ohyama, C. (2017). Serum Aberrant N-Glycan Profile as a Marker Associated with Early Antibody-Mediated Rejection in Patients Receiving a Living Donor Kidney Transplant. International Journal of Molecular Sciences, 18(8), 1731. https://doi.org/10.3390/ijms18081731